Ibogaine is gaining attention as a potential treatment for addiction, particularly opioid dependence, often described as a “reset” for the brain. However, despite growing interest, it remains poorly understood, unapproved in the United States, and primarily used in international settings. Understanding its history, pharmacology, and current applications is essential to evaluating its role in modern addiction treatment.